affinivax.com
Home | AffinivaxAffinivax is developing a next generation vaccine technology platform based on its proprietary platform, the Multiple Antigen Presenting System (MAPS).
http://www.affinivax.com/
Affinivax is developing a next generation vaccine technology platform based on its proprietary platform, the Multiple Antigen Presenting System (MAPS).
http://www.affinivax.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
2 seconds
None
Kamran Tavangar
190 G●●●●●treet
LEX●●●TON , MA, 02420
UNITED STATES
View this contact
None
Adam Farrar
11251 Nort●●●●●●●●●● suite 400
Ho●●on , TX, 77092
UNITED STATES
View this contact
None
Adam Farrar
11251 Nort●●●●●●●●●● suite 400
Ho●●on , TX, 77092
UNITED STATES
View this contact
BUY YOUR DOMAIN
10
YEARS
4
MONTHS
11
DAYS
LAUNCHPAD.COM, INC.
WHOIS : whois.launchpad.com
REFERRED : http://www.launchpad.com
PAGES IN
THIS WEBSITE
9
SSL
EXTERNAL LINKS
6
SITE IP
192.254.234.247
LOAD TIME
2.016 sec
SCORE
6.2
Home | Affinivax | affinivax.com Reviews
https://affinivax.com
Affinivax is developing a next generation vaccine technology platform based on its proprietary platform, the Multiple Antigen Presenting System (MAPS).
affinivax.com
About | Affinivax
http://affinivax.com/about
New Approach to Develop Vaccines. Affinivax is a biotechnology company developing a next generation approach in vaccine technologies with the goal of designing vaccines that provide broad protection against challenging diseases afflicting children and adults in both the developing and developed worlds. The company is rapidly advancing a lead program targeting. Pneumococcus), a pathogen that is responsible for significant morbidity and mortality in children and adults worldwide. Affinivax was establis...
Management Team | Affinivax
http://affinivax.com/about/management-team
New Approach to Develop Vaccines. Steven Brugger, President and CEO. Kamran Tavangar, PhD, Chief Operating Officer.
Vaccine Pipeline | Affinivax
http://affinivax.com/vaccine-pipeline
New Approach to Develop Vaccines. Lead Vaccine Program for Streptococcus Pneumoniae. Affinivax is advancing a lead program in. Pneumococcus), a pathogen that is responsible for considerable morbidity and mortality worldwide. In Affinivax’s MAPS vaccine against pneumococcus. Data with Affinivax’s prototype MAPS vaccine against. In collaboration with its partner, ClearPath Development Company (with support from Astellas Pharma Inc.), Affinivas is advancing its second program using MAPS to develop vacci...
Collaborations | Affinivax
http://affinivax.com/vaccine-pipeline/collaborations
New Approach to Develop Vaccines. Astellas – Pneumococcal Vaccine. Affinivax and Astellas have entered into an exclusive worldwide license agreement to develop and commercialize a vaccine targeting. PATH – Pneumococcal Infections. Affinivax initiated a collaboration with PATH in early 2015 to help support the advancement of it lead MAPS vaccine candidate for. Pneumococcal disease). The partnership includes funding from PATH to support product development, preclinical testing and manufacturing, with t...
News | Affinivax
http://affinivax.com/news
New Approach to Develop Vaccines. February 28, 2017. Astellas and Affinivax Announce Worldwide Partnership for MAPS Vaccine targeting Pneumococcal Disease. February 5, 2016. Affinivax Secures Additional Funding to Advance its Novel Pneumococcal Vaccine towards Clinical Trials. October 26, 2015. Affinivax Announces Collaboration with ClearPath and Astellas to Develop Vaccines to Prevent Nosocomial Infections. Februrary 12, 2015. October 30, 2014. October 30, 2014.
TOTAL PAGES IN THIS WEBSITE
9
The Yates Network | Our Clients
http://www.theyatesnetwork.com/clients.html
Representative clients include biotech and life sciences companies at all stages, from companies with emerging science and pipelines to public companies with multiple products. Is creating novel vaccines that provide the highest level of protection against challenging infectious diseases, based on its proprietary vaccine technology platform. Is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as RNA interference, or RNAi. Is using its Organs-on-C...
Boston Children's Hospital's Startup Companies | Boston Children's Hospital TIDO
http://www.childrensinnovations.org/Pages/ForIndustry/bdFAQs.aspx
Apply for Tech Dev Funds. Sign up for Newsletter. Licensing Managers by Dept. MTAs, CDAs and Consulting. Proof of Concept Grant. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Patents and Licensing Group. Licensing Managers by Dept. Business Development and Marketing Group. Business and Administration Group. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Business Development and Partnering.
Boston Children's Hospital's Startup Companies | Boston Children's Hospital TIDO
http://www.childrensinnovations.org/Pages/Highlights/StartUps.aspx
Apply for Tech Dev Funds. Sign up for Newsletter. Licensing Managers by Dept. MTAs, CDAs and Consulting. Proof of Concept Grant. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Patents and Licensing Group. Licensing Managers by Dept. Business Development and Marketing Group. Business and Administration Group. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Business Development and Partnering.
Boston Children's Hospital's Startup Companies | Boston Children's Hospital TIDO
http://www.childrensinnovations.com/Pages/Highlights/StartUps.aspx
Apply for Tech Dev Funds. Sign up for Newsletter. Licensing Managers by Dept. MTAs, CDAs and Consulting. Proof of Concept Grant. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Patents and Licensing Group. Licensing Managers by Dept. Business Development and Marketing Group. Business and Administration Group. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Business Development and Partnering.
Boston Children's Hospital's Startup Companies | Boston Children's Hospital TIDO
http://www.childrensinnovations.org/Pages/PatentsAndLicensing/Policies.aspx
Apply for Tech Dev Funds. Sign up for Newsletter. Licensing Managers by Dept. MTAs, CDAs and Consulting. Proof of Concept Grant. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Patents and Licensing Group. Licensing Managers by Dept. Business Development and Marketing Group. Business and Administration Group. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Business Development and Partnering.
Technology Newsletter | Boston Children's Hospital TIDO
http://www.childrensinnovations.com/Pages/General/NewsletterAlerts.aspx
Apply for Tech Dev Funds. Sign up for Newsletter. Licensing Managers by Dept. MTAs, CDAs and Consulting. Proof of Concept Grant. Licensed Products in Clinical Trials. Licensed Products on the Market. News and Press Releases. Patents and Licensing Group. Licensing Managers by Dept. Business Development and Marketing Group. Business and Administration Group. Boston Children's Hospital's Startup Companies. Rarr; Booz Allen Hamilton. CoStim Pharmaceuticals → Novartis. Premacure → Shire.
TOTAL LINKS TO THIS WEBSITE
6
Affinium Data Services
Our appologies, The website is currently for our clients only. We are working on a public facing site which will be released soon. Check back again. Thanks!
affinium
Do you find yourself in any of these unfortunate circumstanaces? Own a Vacant House. Have a House in Probate or an Estate Sale. Own a Rental Property with Bad Tenants. We are NOT realtors looking to list your house for sale. We are local real estate investors, helping people to prevent foreclosures, bankruptcy and other circumstances from staining their credit history. We also purchase unwanted houses that need to be sold quickly, aren't currently sellable or just haven't sold. Back to main menu.
Affinium Services in Lombard, Il
Together we create solutions. Success is nothing without a roadmap for the future. We listen carefully TO YOUR needs and goals. The organization was founded in 2013 by Chris based on the needs of nonprofits and small businesses. Knowledgeable and dedicated staff to meet your organizational needs. Set goals to position yourself in key markets. WE CREATE SOUND SOLUTIONS. To provide innovative opportunities that create successful and sustainable outcomes for nonprofits and small businesses.
Employee Discount Program
Employee Retention and Recognition. An employee discount program such as EmployeeMall is the best way to retain, reward, and motivate employees for a very low cost. As a perks program, a good employee discount shopping program will provide your staff with discount tickets, savings on travel, as well as money back on homes and apartments, savings on clothing, computer discounts, electronics, recreation, and more.
Home | Affinivax
New Approach to Develop Vaccines. Affinivax is developing novel vaccines based on its proprietary technology platform, the Multiple Antigen Presenting System (MAPS). Working with world experts in vaccine discovery and development, Affinivax is building a pipeline of innovative vaccines to achieve broader protection against a wide range of diseases, including those for which there are no effective vaccines available today. Learn More ➤. Novel Vaccines with Broader Protection for Global Impact.
Affinix Software
The Closest Thing To Infinity. Elcome to the official homepage of Affinix Software! Find the latest details about our groundbreaking Game Boy COLOR. In the projects page. Read about our company in the information page. Meet our crew in the about page. And be sure to send in your comments. After your stay at Affinix! February 1st, 2007]. Justin went on to found the Psi IM client. Project, and he continues to use the Affinix name for things (despite them having no relation to gaming). The status of the oth...
Welcome to Affin Moneybrokers
Sitio no disponible en este momento. Intente más tarde.
Este dominio se encuentra vencido. Si Usted es el propietario de este dominio, por favor, comuníquese a la brevedad con su entidad registrante.
